Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Bissonnette

Showing results (21-30 of 222) with videos related to

Pageof 23
Sort By:
Archives of Dermatological Research|July 13, 2002
Weekly topical application of methyl aminolevulinate followed by light exposure delays the appearance of UV-induced skin tumours in miceSoraya Sharfaei, Petras Juzenas, Johan Moan, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 11, 2021
Measuring Atopic Dermatitis Disease Severity: The Potential for Electronic Tools to Benefit Clinical CareLaura Maintz, Thomas Bieber, Robert Bissonnette, et al.
Journal of Cutaneous Medicine and Surgery|January 8, 2010
Preface: real-world clinical experience with alefacept-the Amevive Wisdom Acquired from Real-World Evidence (AWARE) studyGordon Searles, Robert Bissonnette, Ian Landells, et al.
Journal of Cutaneous Medicine and Surgery|June 12, 2008
Open-label study to assess the safety and efficacy of imiquimod 5% cream applied once daily three times per week in cycles for treatment of actinic keratoses on the headJason K Rivers, Les Rosoph, Nathalie Provost, et al.
Journal of the American Academy of Dermatology|October 7, 2024
Hand Eczema. Part 1: epidemiology, pathogenesis, diagnosis and work-upRobert Bissonnette, Tove Agner, Sonja Molin, et al.
Journal of Cutaneous Medicine and Surgery|January 8, 2010
The next phase of real-world clinical experience with alefacept: the AWARE-2 registryGordon Searles, Robert Bissonnette, Ian Landells, et al.
The Journal of Dermatological Treatment|July 28, 2012
Effect of adalimumab on sleep parameters in patients with psoriasis and obstructive sleep apnea: a randomized controlled trialCatherine Maari, Chantal Bolduc, Simon Nigen, et al.
Journal of the American Academy of Dermatology|August 31, 2025
In response to: "Response to Bissonnette et al. Dupilumab treatment restores lesional and non-lesional skin barrier function in adults and adolescents with atopic dermatitis irrespective of the filaggrin genotype: Results from an open-label, healthyRobert Bissonnette, Elena Goleva, Evgeny Berdyshev, et al.
Journal of the American Academy of Dermatology|December 29, 2016
Olumacostat glasaretil, a novel topical sebum inhibitor, in the treatment of acne vulgaris: A phase IIa, multicenter, randomized, vehicle-controlled studyRobert Bissonnette, Yves Poulin, Janice Drew, et al.
Journal of Cutaneous Medicine and Surgery|January 9, 2018
Topical Vitamin E Cream Does Not Prevent Visible Light-Induced PigmentationAlexandra Mereniuk, Philippe Marchessault, Catherine Maari, et al.
Pageof 23

Showing results (21-30 of 222) with videos related to

Sort By:
Pageof 23
Archives of Dermatological Research|July 13, 2002
Weekly topical application of methyl aminolevulinate followed by light exposure delays the appearance of UV-induced skin tumours in miceSoraya Sharfaei, Petras Juzenas, Johan Moan, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 11, 2021
Measuring Atopic Dermatitis Disease Severity: The Potential for Electronic Tools to Benefit Clinical CareLaura Maintz, Thomas Bieber, Robert Bissonnette, et al.
Journal of Cutaneous Medicine and Surgery|January 8, 2010
Preface: real-world clinical experience with alefacept-the Amevive Wisdom Acquired from Real-World Evidence (AWARE) studyGordon Searles, Robert Bissonnette, Ian Landells, et al.
Journal of Cutaneous Medicine and Surgery|June 12, 2008
Open-label study to assess the safety and efficacy of imiquimod 5% cream applied once daily three times per week in cycles for treatment of actinic keratoses on the headJason K Rivers, Les Rosoph, Nathalie Provost, et al.
Journal of the American Academy of Dermatology|October 7, 2024
Hand Eczema. Part 1: epidemiology, pathogenesis, diagnosis and work-upRobert Bissonnette, Tove Agner, Sonja Molin, et al.
Journal of Cutaneous Medicine and Surgery|January 8, 2010
The next phase of real-world clinical experience with alefacept: the AWARE-2 registryGordon Searles, Robert Bissonnette, Ian Landells, et al.
The Journal of Dermatological Treatment|July 28, 2012
Effect of adalimumab on sleep parameters in patients with psoriasis and obstructive sleep apnea: a randomized controlled trialCatherine Maari, Chantal Bolduc, Simon Nigen, et al.
Journal of the American Academy of Dermatology|August 31, 2025
In response to: "Response to Bissonnette et al. Dupilumab treatment restores lesional and non-lesional skin barrier function in adults and adolescents with atopic dermatitis irrespective of the filaggrin genotype: Results from an open-label, healthyRobert Bissonnette, Elena Goleva, Evgeny Berdyshev, et al.
Journal of the American Academy of Dermatology|December 29, 2016
Olumacostat glasaretil, a novel topical sebum inhibitor, in the treatment of acne vulgaris: A phase IIa, multicenter, randomized, vehicle-controlled studyRobert Bissonnette, Yves Poulin, Janice Drew, et al.
Journal of Cutaneous Medicine and Surgery|January 9, 2018
Topical Vitamin E Cream Does Not Prevent Visible Light-Induced PigmentationAlexandra Mereniuk, Philippe Marchessault, Catherine Maari, et al.
Pageof 23